RJA
PCM

Raymond James & Associates’s PCM Fund PCM Stock Holding History

Raymond James & Associates’s Portfolio PCM Stock Details PCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$143K Sell
17,924
-9,977
-36% -$77.1K ﹤0.01% 3731
2024
Q2 		$207K Buy
27,901
+686
+3% +$5.75K ﹤0.01% 3582
2024
Q1 		$225K Buy
27,215
+694
+3% +$5.68K ﹤0.01% 3551
2023
Q4 		$211K Buy
26,521
+690
+3% +$5.49K ﹤0.01% 3493
2023
Q3 		$230K Buy
25,831
+894
+4% +$8.44K ﹤0.01% 3386
2023
Q2 		$240K Sell
24,937
-5,822
-19% -$54.3K ﹤0.01% 3384
2023
Q1 		$259K Buy
30,759
+579
+2% +$5.16K ﹤0.01% 3335
2022
Q4 		$238K Buy
30,180
+591
+2% +$4.91K ﹤0.01% 3348
2022
Q3 		$236K Buy
29,589
+1,595
+6% +$15.3K ﹤0.01% 3341
2022
Q2 		$259K Sell
27,994
-1,747
-6% -$17.5K ﹤0.01% 3326
2022
Q1 		$303K Buy
29,741
+424
+1% +$4.5K ﹤0.01% 3411
2021
Q4 		$314K Buy
29,317
+395
+1% +$4.4K ﹤0.01% 3412
2021
Q3 		$328K Buy
28,922
+5,016
+21% +$58.4K ﹤0.01% 3352
2021
Q2 		$284K Buy
23,906
+3,718
+18% +$43.6K ﹤0.01% 3474
2021
Q1 		$231K Sell
20,188
-4,618
-19% -$51.9K ﹤0.01% 3523
2020
Q4 		$266K Buy
24,806
+402
+2% +$4.14K ﹤0.01% 3199
2020
Q3 		$247K Buy
24,404
+416
+2% +$4.04K ﹤0.01% 3070
2020
Q2 		$226K Buy
23,988
+433
+2% +$3.88K ﹤0.01% 3062
2020
Q1 		$187K Sell
23,555
-1,524
-6% -$16.2K ﹤0.01% 3063
2019
Q4 		$287K Buy
25,079
+717
+3% +$8.18K ﹤0.01% 3106
2019
Q3 		$271K Buy
24,362
+899
+4% +$10K ﹤0.01% 3082
2019
Q2 		$266K Buy
23,463
+2,430
+12% +$27.5K ﹤0.01% 3081
2019
Q1 		$234K Buy
21,033
+859
+4% +$9.24K ﹤0.01% 3131
2018
Q4 		$205K Buy
20,174
+4,400
+28% +$46.2K ﹤0.01% 3116
2018
Q3 		$178K Hold
15,774
– – ﹤0.01% 3330
2018
Q2 		$181K Hold
15,774
– – ﹤0.01% 3289
2018
Q1 		$179K Hold
15,774
– – ﹤0.01% 3165
2017
Q4 		$183K Hold
15,774
– – ﹤0.01% 3088
2017
Q3 		$184K Hold
15,774
– – ﹤0.01% 3073
2017
Q2 		$177K Hold
15,774
– – ﹤0.01% 3019
2017
Q1 		$160K Buy
15,774
+25
+0.2% +$255 ﹤0.01% 2986
2016
Q4 		$157K Hold
15,749
– – ﹤0.01% 2945
2016
Q3 		$157K Buy
+15,749
New +$158K ﹤0.01% 2923

Other funds holding PCM

FAIM
Financial Advocates Investment Management Olympia, Washington $178M AUM 21.03% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
SCM
SOL Capital Management Rockville, Maryland $206M AUM 17.87% 1-Year Est. Return

Raymond James & Associates's PCM Position: Q3 2024 in Review

Raymond James & Associates reduced its PCM Fund (PCM) stake by 36% in Q3 2024, selling an estimated $77.1K and leaving 17,924 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #3731.

Raymond James & Associates first reported a position in PCM in Q3 2016 and has held it in 33 quarters since. The position peaked at $328K in Q3 2021. 20 funds tracked by Wall St. Rank hold PCM as of Q3 2024.

  • Raymond James & Associates held 17,924 shares of PCM Fund worth $143K as of Q3 2024.
  • Raymond James & Associates sold 9,977 PCM Fund shares in Q3 2024, an estimated $77.1K.
  • PCM Fund made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3731 holding.
  • Raymond James & Associates first reported a position in PCM Fund in Q3 2016 and has held it in 33 quarters since.
  • Raymond James & Associates's PCM Fund position peaked at $328K in Q3 2021.
  • 20 funds tracked by Wall St. Rank held PCM Fund as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.